Announcements Trials
Browse Landscape

Phase

Phase NA 3Phase 4 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Lung Neoplasms 6Neoplasms 4Colonic Neoplasms 3Prostatic Neoplasms 2Patient Satisfaction 2Ovarian Neoplasms 2Breast Neoplasms 2Brain Neoplasms 2Urinary Bladder Neoplasms 1Tuberculosis, Pulmonary 1Thoracic Diseases 1Supratentorial Neoplasms 1Stomach Ulcer 1Stomach Neoplasms 1Recurrence 1Rectal Neoplasms 1Polyps 1Pituitary Neoplasms 1Pain, Postoperative 1Pain 1Overweight 1Obesity 1Neurofibromatoses 1Neoplastic Cells, Circulating 1Neoplasm Metastasis 1Mouth Neoplasms 1Melanoma 1Liver Neoplasms 1Kidney Neoplasms 1Hypoxia 1

Interventions

remimazolam 1Sugammadex 1Sodium Chloride 1Saline Solution 1Pyridostigmine Bromide 1Propofol 1Neuroleptanalgesia 1Nalbuphine 1Ketamine 1Injections 1Ibuprofen 1Acetaminophen 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Emergence Delirium × Propofol × Clear all
NCT04532606 2025-07-30

Impact of Remimazolam on Prognosis After Bladder Cancer Surgery

Peking University First Hospital

Phase 4 Recruiting
1,128 enrolled
Genitourinary

Emergence Delirium, Urinary Bladder Neoplasms, Delirium

Data powered by HemOnc (CC BY 4.0) Colophon âš¡